Gargling with povidone-iodine may reduce salivary viral load in COVID-19 patients


A prospective, randomized, open-level clinical trial demonstrates that gargling with povidone-iodine accelerates viral clearance and reduces saliva infectivity in patients with asymptomatic or mild coronavirus disease 2019 (COVID-19). The trial findings have been published in the journal Scientific Reports.

Study implicates gut microbiome health in Parkinson’s disease

Previous article

Diabetes Management Tech for Type II patients: Interview with Jeffrey Brewer, CEO of Bigfoot Biomedical

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News